Having lost Merck partnership, Artiva looks to IPO to fund NK cell therapy 01.07.2024 14:50 Fiercebiotech.com Having lost Merck partnership, Artiva looks to IPO to fund NK cell therapy jwaldron Mon, 07/01/2024 - 07:50